Newborns from women infected with COVID-19: somatic and metabolic status.

To date, there are limited data regarding manifestations of new coronavirus infection in infants born of SARS-CoV-2 infected mothers, so the aim of this study is to investigate somatic and metabolic status of newborn infants born to mothers diagnosed with COVID-19. The investigation was carried out on the bases of Laboratory Diagnostic Department of Samara Regional Clinical Hospital named after V.D. Seredavin and the Department of Fundamental and Clinical Biochemistry with Laboratory Diagnostics of Samara State Medical University. Under observation were 85 newborns, including 35 born of healthy mothers and 50 born of COVID-19 mothers.The somatic status of all newborns was assessed using the Apgar scale at the 1st and 5th minutes after birth. Also all newborns had general and biochemical blood tests and newborns from mothers with COVID-19 were tested for the presence of SARS-CoV-2 RNA in oral and nasopharyngeal swabs. Thus, the study of somatic status revealed that of 50 neonates from women infected with COVID-19, only 18% were practically healthy, the rest had signs of prematurity, hypotrophy, perinatal CNS damage, diabetic fetopathy, pulmonary atelectasis, delayed intrauterine development, asphyxia. The metabolic state is characterised by decreased haemoglobin and platelets, increased concentration of total protein, including C-reactive protein, high transaminase activity, decreased sodium and chloride content. These parameters of general and biochemical blood tests can be considered as indicators for the evaluation of the condition of newborns from mothers with COVID-19.

[The effect of hyperglycemia on indices of biochemical blood analysis in vitro.]

The purpose of study was to detect possible deviations between the results of biochemical analysis of blood and true values in conditions of hyperglycemia in vitro and dependences of the given alterations from group belonging of analyzed blood. The biochemical analysis was applied to blood samples of patients with various blood groups according system AB0 in conditions of normo- and hyperglycemia in vitro. The criterion for choice was established the content of main biochemical indices of blood (total protein, total bilirubin, glucose, total cholesterol, urea, creatinine, activity of hylaninamitotransferase (ALT), aspartataminotransferase (AST), lactatedehydrogenase (LDG)) within the reference limits. The hyperglycemia was developed in vitro using 5% glucose solution and corresponded to 20,49±0,05 and 46,37±0,63 mmol/l. The content of total protein and total cholesterol turned out to be the most stable indices. The effect of increased level of glucose to following analytes was established: total bilirubin (+10,5%), ALT activity (±13,4%), AST activity (+11,1%) and creatinine (+51,4%). The alterations of indices up to level of ±10% and higher are clinically significant and have to be taking into account by physicians of clinical laboratory diagnostic and clinical physicians during interpretations of the results of biochemical analysis of blood for evaluation of true picture of condition of patient. The AB0-group specific characteristics of biochemical analysis of blood are established in conditions of hyperglycemia. The hyperglycemia is an interfering factor during implementation of laboratory analysis that is especially actual at interpretations of results of biochemical analysis of blood in patients of reanimation department and individuals suffering of persistent and severe diabetes mellitus with its complication with nephropathy. Besides, the established group-specific characteristics of hyperglycemia effecting the results of biochemical analysis of blood can be accounted in development of standards and guidelines of personified medicine.